Retension Pharmaceuticals, Inc. (RTSN)

Retension Pharmaceuticals, Inc. (RTSN) is a company listed on the NASDAQ.

As of Oct 23, 2026: returns 1 day -1.6%, 1 week +8.4%.

Retension Pharmaceuticals, Inc. (NASDAQ: RTSN) is a clinical-stage biopharmaceutical company focused on the development of therapeutics for cardiovascular disorders, specifically uncontrolled and resistant hypertension.

Groups RTSN belongs to

• Clinical Stage Biopharma
• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Cardiovascular Therapies
• Healthcare
• Pharmaceuticals

RTSN financial model: income statement, cash flow and balance sheet